# Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

> **NCT00009815** · PHASE1 · WITHDRAWN · sponsor: **University of Pittsburgh**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** etoposide
- **DRUG:** leucovorin calcium
- **DRUG:** tegafur-uracil

## Key facts

- **NCT ID:** NCT00009815
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00009815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00009815, "Combination Chemotherapy in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00009815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*